Therefore, PRDM15 might serve as an effective predictive biomarker of radiosensitivity and a target for radiosensitization in locally advanced rectal cancer patients; these findings may contribute to the precise treatment strategies in clinical practice in the future (Fig. 8F). Here, PRDM15 is linked to rectal cancer.